Hengsai Bio

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of personalized dendritic cell tumor vaccines intended to provide new treatment approaches and strategies for relapsed and refractory tumors. Hengsai Bio is based in Shanghai, China and was founded in 2018. It has raised $18.6 million.

Last price · $/share

—

Implied valuation

—

Total raised

$18.6M

Last round

—

How much has Hengsai Bio raised?

$18.6Macross 0 recorded rounds

Free account

More of Hengsai Bio with a free account

·Watch Hengsai Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Hengsai Bio investors

7 investors are on record for Hengsai Bio, including Zhongshan Finance Investment, Fuho Capital, Zhongshan Xiwan Investment Holding Development and CuiHeng Group.

For fundraisers

Raising for a company like Hengsai Bio?

7 investors have backed Hengsai Bio.

See all 7 investors →

Frequently asked about Hengsai Bio

How much has Hengsai Bio raised?: Hengsai Bio has raised $18.6M in total across 0 recorded funding rounds.